메뉴 건너뛰기




Volumn 82, Issue 1, 2007, Pages 87-88

Rediscovery of the susceptibility of G6PD deficient persons to methemoglobinemia from oxidant drugs, and to hemolysis from methylene blue [5]

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPICOLINALDEHYDE THIOSEMICARBAZONE; METHEMOGLOBIN; METHYLENE BLUE; NITRITE; OXIDIZING AGENT;

EID: 33845942408     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20704     Document Type: Letter
Times cited : (7)

References (3)
  • 1
    • 33644508626 scopus 로고    scopus 로고
    • Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine
    • Foltz LM, Dalal BI, Wadsworth LD, et al. Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine. Am J Hematol 2006;81:210-211.
    • (2006) Am J Hematol , vol.81 , pp. 210-211
    • Foltz, L.M.1    Dalal, B.I.2    Wadsworth, L.D.3
  • 3
    • 33845956126 scopus 로고
    • Studies on the mechanism of primaquine-type hemolysis: The effect of methylene blue
    • abstract
    • Brewer GJ, Tarlov AR. Studies on the mechanism of primaquine-type hemolysis: The effect of methylene blue. Clin Res 1961;9:65 (abstract).
    • (1961) Clin Res , vol.9 , pp. 65
    • Brewer, G.J.1    Tarlov, A.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.